Stocks / UNH

Is UnitedHealth Group Incorporated (UNH) a buy right now?

UnitedHealth Group Incorporated · $421

Updated Fri, Oct 23, 6:45 PM ET

UnitedHealth Group Incorporated (UNH) at $421 is a long-term Buy. Business quality is good and valuation is fair value. There is no entry signal today.

Long-termBUY
TodayNO ENTRY SIGNAL

What should I do?

No active entry signal at the current price — check valuation zones and risk. This is current-state context, not a timing forecast.

Business QualitySolid
ValuationFair Value

What we're seeing

The stock is starting to recover, but it is not rising in a clear way.

Today's price is not a good place to start.

Why this rating on UNH

For UnitedHealth Group Incorporated (UNH), business remains attractive.

On UNH, the business remains attractive, but the stock's current setup does not provide a high-confidence entry.

If you already own UNH, keep your existing position. The long-term BUY outlook hasn't changed.

  • •Profitability is under pressure.

What UNH does

UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other…

Common questions

Should I buy UnitedHealth Group Incorporated (UNH) stock?

UnitedHealth Group Incorporated (UNH) is a long-term Buy. Business quality is good and valuation is fair value. That is the long-term call — not a same-day order.

Is UNH a buy right now?

UnitedHealth Group Incorporated (UNH) at $421 is a long-term Buy. Business quality is good and valuation is fair value. There is no entry signal today.

Is UnitedHealth Group Incorporated a good company?

UnitedHealth Group Incorporated (UNH) looks like a good company — solid business quality, not the top tier. Quality still has to be weighed against valuation and today's setup.

Is UnitedHealth Group Incorporated overvalued?

UnitedHealth Group Incorporated (UNH) is not clearly overvalued. Price is near estimated fair value.

Is now a good time to buy UnitedHealth Group Incorporated stock?

There is no entry signal today. On UNH, the business remains attractive, but the stock's current setup does not provide a high-confidence entry. That is today's tape — not the same question as whether UnitedHealth Group Incorporated (UNH) is worth owning.

Why is UNH a long-term Buy?

For UnitedHealth Group Incorporated (UNH), business remains attractive.

Other stock pages

Open UNH analysis

Full report with zones, financials, and today's tape.

Our reports are for informational purposes only and do not constitute financial advice. Investment ratings and written explanations are produced by rule-based quantitative models from market data. Always consult a licensed financial advisor before making investment decisions. We are not liable for investment losses.